Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C8H17NO2 |
Molecular Weight | 159.2261 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C[C@H](CN)CC(O)=O
InChI
InChIKey=AYXYPKUFHZROOJ-ZETCQYMHSA-N
InChI=1S/C8H17NO2/c1-6(2)3-7(5-9)4-8(10)11/h6-7H,3-5,9H2,1-2H3,(H,10,11)/t7-/m0/s1
Molecular Formula | C8H17NO2 |
Molecular Weight | 159.2261 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:45:33 UTC 2023
by
admin
on
Fri Dec 15 15:45:33 UTC 2023
|
Record UNII |
55JG375S6M
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EMA ASSESSMENT REPORTS |
PREGABALIN PFIZER (AUTHORIZED: NEURALGIA)
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PREGABALIN ZENTIVA (AUTHORIZED: EPILEPSY)
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
||
|
WHO-ATC |
N03AX16
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
||
|
WHO-VATC |
QN03AX16
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PREGABALIN SANDOZ GMBH (AUTHORIZED: EPILEPSY)
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
||
|
NCI_THESAURUS |
C264
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
||
|
LIVERTOX |
NBK548053
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PREGABALIN MYLAN PHARMA (AUTHORIZED: EPILEPSY)
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
LYRICA (AUTHORIZED: ANXIETY DISORDERS)
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
LYRICA (AUTHORIZED: NEURALGIA)
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PREGABALIN MYLAN (AUTHORIZED: EPILEPSY)
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
||
|
NCI_THESAURUS |
C2198
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
||
|
DEA NO. |
2782
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PREGABALIN SANDOZ (AUTHORIZED: EPILEPSY)
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
LYRICA (AUTHORIZED: EPILEPSY)
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2255
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
55JG375S6M
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
C64625
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
Pregabalin
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
SUB10023MIG
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
5484
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
148553-50-8
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
759256
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
C080245
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
7530
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
1559618
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
DB00230
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
CHEMBL1059
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
DTXSID1045950
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
55JG375S6M
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
187832
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | RxNorm | ||
|
5486971
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
HH-23
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
m9113
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000091845
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
7643
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
64356
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY | |||
|
PREGABALIN
Created by
admin on Fri Dec 15 15:45:33 UTC 2023 , Edited by admin on Fri Dec 15 15:45:33 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
EXCRETED UNCHANGED |
URINE
|
||
|
TARGET -> INHIBITOR |
ReduceS depolarization-induced calcium influx at nerve terminals, with a consequential reduction in the release of several excitatory neurotransmitters, including glutamate, noradrenaline, substance P, and CGRP.
IC50
|
||
|
INNOVATOR->PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
TARGET->LIGAND |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
ENANTIOMERIC PURITY/HPLC
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
USP
|
||
|
IMPURITY -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
Elimination PHARMACOKINETIC |
|
||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||